摘要
食管癌不仅是目前世界上第八大常见的恶性癌症,也是导致癌症及其相关患者死亡的第六大常见死亡原因。通过免疫检查点抑制剂治疗提高了晚期黑色素瘤、非小细胞肺癌等恶性肿瘤患者的生存和预后。很多临床试验正在评估免疫治疗在食管癌治疗中的疗效和耐受性。本文就免疫检查点抑制剂治疗在食管癌治疗中的临床研究以及进展情况作一综述。
Esophageal cancer is not only the eighth most common malignant cancer in the world, but also the sixth most common cause of death from cancer and its related patients. Treatment with immune checkpoint inhibitors improves survival and prognosis of patients with advanced melanoma and non-small cell lung cancer. Many clinical trials are evaluating the efficacy and tolerability of immu-notherapy in the treatment of esophageal cancer. This article reviews the clinical research and de-velopment of immune checkpoint inhibitors in the treatment of esophageal cancer.
出处
《临床医学进展》
2022年第6期5222-5229,共8页
Advances in Clinical Medicine
